Charlene Young, FNP-BC

Certified Nurse Practitioner
Neurology
Accepting new patients
Call for an appointment
or

    About me

    Charlene works with the Parkinson’s Center and Dale and Deborah Smith Center for Alzheimer’s Research and Treatment and sees Parkinson’s / Movement Disorders, as well as Memory / Dementia patients. She is certified by the American Nurses Credential Center as a certified Family Nurse Practitioner.  She is a member of numerous professional organizations, including the American Academy of Nurse Practitioners. 

    Gender

    Female

    Education & training

    Positions
    Certified Nurse Practitioner
    Neurology
    Board Certifications
    Family Nurse Practitioner
    Medical School
    Illinois State University
    Undergraduate Degree
    Illinois State University Bloomington, IL. Masters of Science in Nursing- Family Nurse Practitioner

    Specialties

    Clinical locations

    Locations

    SIU Neurology Clinic

    751 N. Rutledge St. Springfield, IL 62702
    Mon - Fri: 8:00 am-4:30 pm
    Locations

    SIU Neurology at HSHS St. John's

    415 N. 9th St. Springfield, IL 62701
    Mon - Fri: 8:00 am-4:30 pm

    Hospital privileges

    • HSHS St. John's Hospital, Springfield, IL
    • Memorial Health, Springfield IL

    Research

    Research Interests
    Parkinson's Disease, Alzheimer's Disease, Adult Neurology

    Clinical trials

    Trial
    Neurology

    Roche: An open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term gantenerumab administration in participants with Alzheimer's disease

    Active not recruiting

    POST GRAD: The purpose of this study is to compare the effects, good or bad, of long term gantenerumab on subjects with prodromal or mild Alzheimer's disease. 

    Trial
    Neurology

    Lilly: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

    Active not recruiting

    I5T-MC-AACI: Alzheimer’s is a disease that attacks the brain, causing problems with memory, thinking, and behavior.  Symptoms usually develop slowly and get worse over time, eventually making daily tasks impossible. Although we don’t know the exact cause, researchers found out that the two proteins called tau and amyloid are building up in brains of people with Alzheimer’s disease even before they have any symptoms.

    Trial
    Neurology

    Lilly: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

    Active not recruiting

    I5T-MC-AACI: Alzheimer’s is a disease that attacks the brain, causing problems with memory, thinking, and behavior.  Symptoms usually develop slowly and get worse over time, eventually making daily tasks impossible. Although we don’t know the exact cause, researchers found out that the two proteins called tau and amyloid are building up in brains of people with Alzheimer’s disease even before they have any symptoms.

    Trial
    Neurology

    Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

    Active recruiting

    ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.

    Trial
    Neurology

    Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

    Active recruiting

    ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.